Reversal agents of non-vitamin K dependent anticoagulants: a rapid review of the changing horizon.
The newer non-vitamin K dependent anticoagulants (NOACs) have provided a new tool in the armamentarium of physicians treating nonvalvular atrial fibrillation and thromboembolism. Slowly, but steadily, there has been an increased preference of NOACs over vitamin K antagonists. However, the major limiting factor and the concern that precluded their use was lack of reversal in emergent situations. With the advent of reversal agents such as idarucizumab, andexanet alfa and PER977, this gap is also being filled. This will further increase the spectrum of usage of NOACs. In this review we present the detailed information on the completed trials on the reversal agents, the ongoinng trials, and their site of action. The reversal agent idarucizumab is FDA approved and readily available. The others are in clinical trials and are soon expected to be available in clinical practice.
Department of Medicine, Saint Joseph Regional Medical Center, Paterson, New Jersey, USA.
Supreet
S
Kaur
Department of Medicine, Saint Joseph Regional Medical Center, Paterson, New Jersey, USA.
Abhishek
A
Kumar
Division of Hematology, Westchester Medical Center/New York Medical College, Valhalla, NY, USA.
Robert G
RG
Lerner
Division of Cardiology, Westchester Medical Center/New York Medical College, Valhalla, NY, USA.
Wilbert S
WS
Aronow
PER977; andexanet alfa; idarucizumab; non-vitamin K dependent anticoagulants
Biomed Res Int. 2015;2015:345138
26090400
N Engl J Med. 2015 Aug 6;373(6):511-20
26095746
Blood. 2013 May 2;121(18):3554-62
23476049
Thromb Haemost. 2015 May;113(5):943-51
25789661
Lancet. 2015 Aug 15;386(9994):680-90
26088268
J Thromb Thrombolysis. 2014;37(2):217-33
23860880
N Engl J Med. 2015 Dec 17;373(25):2413-24
26559317
N Engl J Med. 2014 Nov 27;371(22):2141-2
25371966
Clin Chem Lab Med. 2015 Nov;53(12):1981-90
25901716
Heart. 2010 Apr;96(7):498-503
19713203
Ann Neurol. 2015 Jul;78(1):137-41
25899749
Curr Pharm Des. 2013;19(21):3816-26
23286429
Nat Med. 2013 Apr;19(4):446-51
23455714